Gilead profit beats Street expectations on COVID and HIV sales
Go back to Gilead profit beats Street expectations on COVID and HIV sales| Gilead Sciences (NASDAQ: GILD) | Delayed: 123.94 +0.18 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.76 | 52 Week High | $108.63 | |||
| Open | $124.30 | 52 Week Low | $71.39 | |||
| Day High | $124.50 | P/E | 68.48 | |||
| Day Low | $123.00 | EPS | $1.81 | |||
| Volume | 1,317,703 | |||||
